NR 606 Week 4 Midterm Exam Study Guide

NR606 – Diagnosis and Management in Psychiatric-Mental Health II Exam Study Guide – Midterm Exam 914400127664 Exam Format: Non-Cumulative exam Question Type: Multiple Choice Number of Questions: 75 Number of Points: 150 points Time Allotted: 90 Minutes Testing Timeframe: The midterm exam will be available starting on Wednesday of Week 4 at 12:01 am MT until Friday of Week 4 at 11:59 pm MT. 91440075770 Exam Coverage Content Areas: Week 1: 0361023 Ethical Considerations in Treating Children and Adolescents Privacy and HIPAA Informed consent Prescribing considerations Mandatory reporting Prescribing Considerations for Maternal Mental Health Treatment Considerations during pregnancy Considerations for breastfeeding Substance Use Disorder in the Perinatal Period Substance risks Ethical and legal considerations Stigma Assessment and screening Treatment 914400176675 0361023Key Concepts to Study What are barriers to seeking mental health care in children, adolescents and perinatal populations Social determinants and access to care in children and adolescents Developmentally appropriate teaching in children and adolescents Racial and ethnic barriers to treatment Know types of stigma: structural, self, public, intervention Parental access to child/adolescent’s mental health records – legal aspects Ethical and legal principles of informed consent Mandatory reporting Explore physiologic differences in children that influence medication absorption, distribution, metabolism, and excretion. Understand the principles of dosing medications for children, including weight-based calculations and safety considerations. Recommended Resources Canvas Modules: Week 1 Textbook Chapters: Preston, J. D., O’Neal, J. H., Talaga, M. C., & Moore, B. A. (2021). Child and adolescent clinical psychopharmacology made simple (4th ed.). New Harbinger Publications, Inc. Chapter 1: Issues in Psychopharmacological Treatment of Children and Adolescents Gallaby, M., Woods, N., & Snellen, M. (2022). How clinicians can support women in making decisions about psychopharmacological treatments in pregnancy World Psychiatry, 21(1), 149-151. https://doi.org/10.1002/wps.20937 Sanmartin, M., Ali, M., Chen, J., & Dwyer, D.S. (2019). Mental health treatment and unmet mental health care need among pregnant women with major depressive episode in the United States . Psychiatric Services, 70(6), 503-506. 914400117798 Exam Coverage Content Areas: Week 2: 0361023 Maternal Mental Health Baby blues Maternal mental health disorders Depression Bipolar II disorder (BPD) Anxiety Obsessive-compulsive disorder (OCD) Posttraumatic stress disorder (PTSD) Psychosis Impact of maternal mental health disorders on pediatric mental health Stigmas associated with maternal mental health disorders Key Concepts to Study Substance abuse in pregnancy, treatment and assessment (know CIWA scoring) Antipsychotic medications: Across the lifespan including children and in pregnancy Risk factors for maternal mental health disorders Depression symptoms in pregnancy: fatigue, guilt and lack of focus. SSRI withdrawal symptoms in newborns with maternal exposure Diagnostic criteria for anxiety and depression in pregnancy and post partum period Anxiety disorders in pregnancy What are the key clinical signs and risk factors for postpartum PTSDTreatment of severe post partum depression Substance abuse (including Tobacco & Cannabis) in pregnancy. What are the recommended initial treatment strategies for addressing tobacco use in pregnant clientsMood stabilizers in pregnancy Acceptable antipsychotics in pregnancy Postpartum psychosis risk factors Laboratory assessment of pregnant patients on antipsychotics Postpartum depression screening Bipolar disorder in pregnancy and in